Electrospun Poly(ε‐Caprolactone)/Silk Fibroin Coaxial Core‐Sheath Nanofibers Applied to Scaffolds and Drug Carriers

2020 ◽  
Vol 60 (4) ◽  
pp. 802-809
Author(s):  
Yahui Zheng ◽  
Dan Su ◽  
Jingjing Yuan ◽  
Li Zha ◽  
Yinghong Xiao ◽  
...  
Keyword(s):  
2020 ◽  
Vol 321 ◽  
pp. 324-347 ◽  
Author(s):  
Mehdi Farokhi ◽  
Fatemeh Mottaghitalab ◽  
Rui L. Reis ◽  
Seeram Ramakrishna ◽  
Subhas C. Kundu

2011 ◽  
Vol 56 (13) ◽  
pp. 1013-1018 ◽  
Author(s):  
YongLi HUANG ◽  
Qiang LU ◽  
HeSun ZHU ◽  
MingZhong LI ◽  
Bing ZHANG

2019 ◽  
Vol 9 (18) ◽  
pp. 3899 ◽  
Author(s):  
Dorel Feldman

Synthetic polymers, biopolymers, and their nanocomposites are being studied, and some of them are already used in different medical areas. Among the synthetic ones that can be mentioned are polyolefins, fluorinated polymers, polyesters, silicones, and others. Biopolymers such as polysaccharides (chitosan, hyaluronic acid, starch, cellulose, alginates) and proteins (silk, fibroin) have also become widely used and investigated for applications in medicine. Besides synthetic polymers and biopolymers, their nanocomposites, which are hybrids formed by a macromolecular matrix and a nanofiller (mineral or organic), have attracted great attention in the last decades in medicine and in other fields due to their outstanding properties. This review covers studies done recently using the polymers, biopolymers, nanocomposites, polymer micelles, nanomicelles, polymer hydrogels, nanogels, polymersomes, and liposomes used in medicine as drugs or drug carriers for cancer therapy and underlines their responses to internal and external stimuli able to make them more active and efficient. They are able to replace conventional cancer drug carriers, with better results.


2013 ◽  
Vol 30 (1) ◽  
pp. 73
Author(s):  
Wei JING ◽  
Jun-sheng LI ◽  
Guo-xia HUANG ◽  
Liu-juan YAN ◽  
Chun-hua LAI

Author(s):  
Kumar P ◽  
S Kumar ◽  
A Kumar ◽  
M Chander

The purpose of this study was to prepare and characterize solid dispersions of the antibacterial agent Cefdinir with PEG 4000 and PVP K-30 with a view to improve its dissolution properties. Investigations of the properties of the dispersions were performed using release studies, X-ray powder diffraction (XRD) and Fourier transform infrared (FTIR). The results obtained showed that the rate of dissolution of Cefdinir was considerably improved when formulated in solid dispersions with PVP K-30 and PEG 4000 as compared with pure drug and physical mixtures. The results from XRD studies showed the transition of crystalline nature of drug to amorphous form, while FTIR studies demonstrated the absence of drug-carriers interaction.


Sign in / Sign up

Export Citation Format

Share Document